| Cvs Pharmacy #16427 | |
| 4390 Montgomery Rd, Ellicott City, Maryland 21043 | |
| (410) 203-1171 |
| Name | Cvs Pharmacy #16427 |
|---|---|
| Organization Name | Maryland Cvs Pharmacy Llc. |
| Location | 4390 Montgomery Rd, Ellicott City, Maryland 21043 |
| Type | Community/Retail Pharmacy |
| Phone | (410) 203-1171 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Imperial College London. The findings, published in the American Journal of Physiology—Regulatory, Integrative, and Comparative Physiology, suggest a new mechanism by which some types of bariatric surgery lead to long-term weight loss.
Maurizio Pellecchia, who holds the Daniel Hays Chair in Cancer Research at the University of California, Riverside, has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
A group of university students are enjoying a specially designed fruit smoothie a day to discover whether it can improve their appearance and make them feel healthier.
› Verified 7 days ago
| NPI Number | 1033404587 |
| Type | Community/Retail Pharmacy |
| Address | 4390 Montgomery Rd, T-1042, Ellicott City, MD 21043 |
| Phone Number | 410-203-1171 |
News Archive
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Imperial College London. The findings, published in the American Journal of Physiology—Regulatory, Integrative, and Comparative Physiology, suggest a new mechanism by which some types of bariatric surgery lead to long-term weight loss.
Maurizio Pellecchia, who holds the Daniel Hays Chair in Cancer Research at the University of California, Riverside, has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
A group of university students are enjoying a specially designed fruit smoothie a day to discover whether it can improve their appearance and make them feel healthier.
› Verified 7 days ago
| NPI Number | 1730101486 |
| Organization Name | MARYLAND CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #16427 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4390 Montgomery Rd, Ellicott City, MD 21043 |
| Phone Number | 410-203-1171 |
News Archive
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Imperial College London. The findings, published in the American Journal of Physiology—Regulatory, Integrative, and Comparative Physiology, suggest a new mechanism by which some types of bariatric surgery lead to long-term weight loss.
Maurizio Pellecchia, who holds the Daniel Hays Chair in Cancer Research at the University of California, Riverside, has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
A group of university students are enjoying a specially designed fruit smoothie a day to discover whether it can improve their appearance and make them feel healthier.
› Verified 7 days ago
News Archive
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
Heart disease is the leading cause of mortality in women worldwide, including in the United States. Although deaths from cardiovascular disease (CVD) in men have declined since the 1970s, the rates of death for women have not followed.
Imperial College London. The findings, published in the American Journal of Physiology—Regulatory, Integrative, and Comparative Physiology, suggest a new mechanism by which some types of bariatric surgery lead to long-term weight loss.
Maurizio Pellecchia, who holds the Daniel Hays Chair in Cancer Research at the University of California, Riverside, has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
A group of university students are enjoying a specially designed fruit smoothie a day to discover whether it can improve their appearance and make them feel healthier.
› Verified 7 days ago
Rite Aid Pharmacy 00384 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8601 Baltimore National Pike, Ellicott City, Maryland 21043 Phone: (410) 480-1377 | |
Enchanted Medical Llc Type: DME Supplier - Dialysis Equipment & Supplies Location: 10040 Baltimore National Pike, Ellicott City, Maryland 21042 Phone: (410) 988-8740 | |
Cvs Pharmacy # 02043 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3300a Centennial Lane, Ellicott City, Maryland 21042 Phone: (410) 750-9439 | |
Cvs Pharmacy #16427 Type: Community/Retail Pharmacy Location: 4390 Montgomery Rd, Ellicott City, Maryland 21043 Phone: (410) 203-1171 | |
Walgreens#17905 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9150 Baltimore National Pike, Ellicott City, Maryland 21042 Phone: (410) 465-4666 |